Journal of Biopharmaceutical Statistics
-
Publication Venue For
- A Bayesian approach to subgroup identification.. 24:110-129. 2014
- A multiple imputation method for sensitivity analyses of time-to-event data with possibly informative censoring.. 24:229-253. 2014
- Authors' response to "comment on: Cheng, Chow, Burt, and Cosmatos (2008). Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables". 20:1074. 2010
- Strategies for adaptive designs with multiple endpoints (Journal of Biopharmaceutical Statistics 17:6 (1189-1200)). 18:402. 2008
- Guest editor's note for the special issue on assessing agreement. 17:525-527. 2007
- A note on sample size calculation based on propensity analysis in nonrandomized trials.. 17:35-41. 2007
- Adaptive group sequential test for clinical trials with changing patient population.. 17:1227-1238. 2007
- An overview on assessing agreement with continuous measurements.. 17:529-569. 2007
- Analysis strategies for adaptive designs with multiple endpoints.. 17:1189-1200. 2007
- Assessing individual agreement.. 17:697-719. 2007
- Assessing observer agreement in studies involving replicated binary observations.. 17:757-766. 2007
- Assessing the consistency of traditional Chinese medicine with multiple correlative active components.. 17:791-808. 2007
- Comparison of concordance correlation coefficient and coefficient of individual agreement in assessing agreement.. 17:721-738. 2007
- Discussion of: Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies. 17:19-21. 2007
- Mixed noninferiority margin and statistical tests in active controlled trials.. 17:339-357. 2007
- Sample size calculation for weighted rank tests comparing survival distributions under cluster randomization: a simulation method.. 17:839-849. 2007
- Statistical analysis for two-stage seamless design with different study endpoints.. 17:1163-1176. 2007
- Rejoinder. 16:781-783. 2006
- Adaptive design in clinical research: issues, opportunities, and recommendations.. 16:299-309. 2006
- Discussion of the "Executive Summary of the PhRMA Working Group on adaptive designs in clinical drug development". 16:287-288. 2006
- Editor's note - JBS is now an SCI journal. 16:273-274. 2006
- On the assessment of dose proportionality: a comparison of two slope approaches.. 16:385-392. 2006
- P-value calculation for multistage phase II cancer clinical trials.. 16:765-775. 2006
- Statistical quality control process for traditional Chinese medicine.. 16:861-874. 2006
- Journal of Biopharmaceutical Statistics: Editor's note. 15:1-2. 2005
- A Bayesian approach on sample size calculation for comparing means.. 15:799-807. 2005
- A hybrid Bayesian adaptive design for dose response trials.. 15:677-691. 2005
- Effect of dropouts on sample size estimates for test on trends across repeated measurements.. 15:33-41. 2005
- Inference for clinical trials with some protocol amendments.. 15:659-666. 2005
- Sample size calculation for simulation-based multiple-testing procedures.. 15:957-967. 2005
- Sample size computation for two-sample noninferiority log-rank test.. 15:969-979. 2005
- Statistical consideration of adaptive methods in clinical development.. 15:575-591. 2005
- Assessing bioequivalence using genomic data.. 14:869-880. 2004
- Cross-validation for linear model with unequal variances in genomic analysis.. 14:723-739. 2004
- Sample size determination based on rank tests in clinical trials.. 13:735-751. 2003
- Stability analysis with discrete responses.. 13:451-462. 2003
- Analysis of survival data with missing measurements of a time-dependent binary covariate.. 13:253-270. 2003
- Chi-square test for R x C contingency tables with clustered data.. 13:241-251. 2003
- Examining outlying subjects and outlying records in bioequivalence trials.. 13:43-56. 2003
- A note on sample size calculation for mean comparisons based on noncentral t-statistics.. 12:441-456. 2002
- On sample size calculation based on odds ratio in clinical trials.. 12:471-483. 2002
- Tests for inter-subject and total variabilities under crossover designs.. 12:503-534. 2002
- Assessing sensitivity and similarity in bridging studies.. 12:385-400. 2002
- Bridging studies in clinical development.. 12:359-367. 2002
- On statistical power for average bioequivalence testing under replicated crossover designs.. 12:295-309. 2002
- On the assessment of similarity for dissolution profiles of two drug products.. 12:311-321. 2002
- Probability lower bounds for USP/NF tests.. 12:79-92. 2002
- Journal of Biopharmaceutical Statistics: Editor's note. 12. 2002
- Estimation of the combined response to treatment in multicenter trials.. 11:275-295. 2001
- Bioequivalence review for drug interchangeability.. 9:485-497. 1999
- Protein construct storage: Bayesian variable selection and prediction with mixtures.. 8:431-443. 1998
- Power considerations when a continuous outcome variable is dichotomized.. 8:337-352. 1998
- Statistical comparison between dissolution profiles of drug products.. 7:241-258. 1997
- A two one-sided tests procedure for assessment of individual bioequivalence.. 7:49-61. 1997
- An adjusted two one-sided t-test for the assessment of bioequivalence with multiple doses.. 7:157-170. 1997
- Meta-analysis for bioequivalence review.. 7:97-111. 1997
- Some thoughts on individual bioequivalence.. 7:41-48. 1997
- An approach to the assessment of therapeutic drug interactions with fixed combination drug products.. 6:231-240. 1996
- Statistical issues in quality-of-life assessment.. 6:37-48. 1996
- On likelihood distance for outliers detection.. 5:307-322. 1995
- On stability designs in drug shelf-life estimation.. 5:201-214. 1995
- The impact of outlying subjects on decision of bioequivalence.. 5:71-94. 1995
- On statistical characteristics of quality of life assessment.. 4:1-17. 1994
- Some general estimation methods for nonlinear mixed-effects models.. 3:23-55. 1993
- On assessment of bioequivalence under a higher-order crossover design.. 2:239-256. 1992
- Assessment of bioequivalence using a multiplicative model.. 1:193-203. 1991
- The estimation of parameters from bulked samples.. 1:1-15. 1991